Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/10/1989 | US4873189 Monoclonal antibodies to bluetongue virus antigen |
10/10/1989 | US4873188 Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies |
10/10/1989 | CA1262238A1 Human monoclonal antibodies against bacterial toxins |
10/05/1989 | WO1989009403A1 Diagnostic methods and systems for quantifying apo ai |
10/05/1989 | WO1989009286A1 PROTAMINE-REACTIVE IgM ANTIBODIES |
10/05/1989 | WO1989009278A1 Method of degrading keratinaceous material and bacteria useful therefor |
10/05/1989 | WO1989009277A1 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
10/05/1989 | WO1989009271A1 Recombinant retroviruses |
10/05/1989 | WO1989009268A1 Production of insulin-like growth factor binding protein |
10/05/1989 | WO1989009264A1 DNA SEQUENCES CONTAINING THE FUNCTIONAL PART OF THE LOCUS sacU AND OF THE LOCUS sacUh OF B. SUBTILIS, VECTORS CONTAINING SAID SEQUENCES AND THEIR USE IN PROTEIN PRODUCING PROCESSES |
10/05/1989 | WO1989009260A1 Ryegrass pollen allergen |
10/05/1989 | WO1989009234A1 Therapeutic murine monoclonal antibody |
10/05/1989 | WO1989009232A1 Neuropeptide antagonists |
10/05/1989 | WO1989009228A1 Peptides |
10/05/1989 | WO1989009227A2 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis |
10/05/1989 | WO1989009223A1 Dna binding proteins including androgen receptor |
10/05/1989 | WO1989009220A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
10/05/1989 | WO1989009219A1 Artificial chromosome vector |
10/05/1989 | DE3810331A1 Monoclonal VAC antibodies |
10/04/1989 | EP0335854A2 Regulated gene expression in gram-negative microorganisms |
10/04/1989 | EP0335635A1 Mutated HIV envelope protein |
10/04/1989 | EP0335567A2 Controlled release of periplasmic proteins into the medium |
10/04/1989 | EP0335550A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
10/04/1989 | EP0335243A2 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
10/04/1989 | EP0335135A2 Production of monoclonal antibodies specific for non-A, non-B hepatitis infected liver |
10/04/1989 | EP0335134A2 Mouse monoclonal antibody to human immunodeficiency virus gp41 protein |
10/04/1989 | EP0334958A1 Monoclonal antibodies |
10/04/1989 | CN1036034A Method and apparatus for culture in acetic acid as indication |
10/04/1989 | CN1035953A Binding-inducing composition |
10/03/1989 | US4871835 Analogs of hGH having antagonistic activity, and uses thereof |
10/03/1989 | US4871834 Anticarcinogenic agents, genetic engineering |
10/03/1989 | US4871670 Dna transfer vector |
10/03/1989 | US4871663 Exporession vector for human TnF |
09/27/1989 | EP0334687A1 Immunoassays for incipient diabetes |
09/27/1989 | EP0334301A1 Recombinant retroviruses |
09/27/1989 | EP0334278A2 Process of purification of a 168kD protein from Mycoplasma pneumoniae |
09/27/1989 | EP0334165A2 Monoclonal antibodies |
09/27/1989 | CN1035845A Cloning and expression of transforming growth factor beta 2 |
09/26/1989 | US4870163 Purification by multistage adsorption |
09/26/1989 | US4870159 Leucine-specific regulatory locus |
09/26/1989 | US4870017 Bacterial methionine N-terminal peptidase |
09/26/1989 | EP0329693A4 Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same. |
09/26/1989 | EP0216864A4 Detection of activated platelets with antibodies to cell surface antigens. |
09/26/1989 | CA1261286A2 Antigens and monoclonal antibodies reactive against merozoites of eimeria spp |
09/26/1989 | CA1261285A2 Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp |
09/26/1989 | CA1260859A1 Peptide antibiotics |
09/26/1989 | CA1260858A1 Expression using fused genes providing for protein product |
09/26/1989 | CA1260827A1 Antibody-metal ion complexes |
09/26/1989 | CA1259921A1 Non-a non-b hepatitis antigens |
09/26/1989 | CA1259920A1 Immunotoxin and method of making |
09/21/1989 | WO1989008845A1 Antibodies, process for producing them, oligosaccharide haptens and clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
09/21/1989 | WO1989008843A1 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection |
09/21/1989 | WO1989008842A1 Placental isoferritins for the prognosis and diagnosis of immunosuppression |
09/21/1989 | WO1989008711A1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
09/21/1989 | WO1989008710A1 Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
09/21/1989 | WO1989008709A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
09/21/1989 | WO1989008667A1 Recombinant igf binding protein (ibp-1) |
09/21/1989 | WO1989008665A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |
09/21/1989 | DE3907192A1 Verfahren zur durchfuehrung einer enzymatischen reaktion und vorrichtung zur durchfuehrung derselben A method for performing enzymatic reaction and apparatus for carrying out the same |
09/21/1989 | DE3906871A1 Process for the preparation of human leucocyte interferon |
09/21/1989 | DE3807594A1 Antikoerper, verfahren zu ihrer herstellung, oligosaccharid-haptene und klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren Antibodies, methods for their manufacture, oligosaccharide haptens and clones for production of antibodies and use of antibodies for diagnosis and therapy of tumors |
09/20/1989 | EP0333691A2 A recombinant fusion protein, its use and a recombinant vector |
09/20/1989 | EP0333574A2 Human nerve growth factor |
09/20/1989 | EP0333528A1 Use in the food industry of micro-organisms expressing transglutaminase genes for structuring protein-containing mixtures |
09/20/1989 | EP0333444A2 Fast track method for producing monoclonal bi-specific immunoglobuline |
09/20/1989 | EP0333177A2 FR-900493 substance, a process for its production and a pharmaceutical composition containing the same |
09/20/1989 | EP0333134A2 Gentechnological preparation of protein PP 15. |
09/20/1989 | EP0332879A2 Monoclonal antibody recognizing un-natural ganglioside GD3 |
09/20/1989 | EP0332677A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
09/20/1989 | EP0332667A1 Vector for integration site independent gene expression in mammalian host cells |
09/20/1989 | EP0332660A1 Bioadhesives |
09/20/1989 | EP0332659A1 Immunogenic glycopeptides of human cytomegalovirus |
09/20/1989 | EP0332640A1 Recombinant alzheimer's amyloid protein |
09/20/1989 | CN1035679A Nanbv diagnostics and vaccines |
09/19/1989 | US4868171 Antibiotic A 40926 N-acylaminoglucuronyl aglycons and antiobiotic A 40926 aglycon |
09/19/1989 | US4868118 Cloning and expression of the 47-kilodalton antigen of treponema pallidum |
09/19/1989 | US4868113 Recombinant DNA vector encoding human endothelial cell growth factor |
09/19/1989 | US4868112 Novel procoagulant proteins |
09/19/1989 | US4868111 Gram-positive expression control sequences |
09/19/1989 | EP0267275A4 A DNA SEQUENCE ENCODING THE -i(ROS) ONCOGENE, POLYPEPTIDES ENCODED THEREFROM, AND DIAGNOSTIC AND OTHER METHODS BASED THEREON. |
09/19/1989 | EP0232255A4 Immunochemical assays for human amylase isoenzymes and related monoclonal antibodies, hybridoma cell lines and production thereof. |
09/19/1989 | CA1259566A1 Vaccines and compositions against hepatitis b viral infections |
09/14/1989 | DE3907114A1 Process for the preparation of cytokines |
09/13/1989 | EP0342188A1 Method for the removal of undesired cells from human lymphocyte populations, application of the method in monoclonal antibody production and kit therefor. |
09/13/1989 | EP0332576A2 Modified proteins |
09/13/1989 | EP0332523A1 Hirudin variants, their use and process for their preparation |
09/13/1989 | EP0332488A1 Method for the integration of a chosen gene into a bacterial chromosome, and bacterium obtained by said method |
09/13/1989 | EP0332424A2 Chimeric antibodies directed against human carcinoembryonic antigen |
09/13/1989 | EP0332421A2 Monoclonal antibodies recognizing human PSTI, hybridomas producing the same, and their preparation and use |
09/13/1989 | EP0332369A2 Antibiotic |
09/13/1989 | EP0332225A2 Antibody to polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
09/13/1989 | EP0332022A2 Magnetic protein conjugates, process for their production and their use |
09/13/1989 | EP0331961A2 Method for protein synthesis using CKS fusion proteins |
09/13/1989 | EP0331821A1 Antiviral agent |
09/13/1989 | EP0331743A1 Protein derived from living body |
09/13/1989 | CN1035527A Vectors and compounds for direct expression of activated human protein c |
09/12/1989 | US4866033 Oligopeptides from bovine blood |
09/12/1989 | US4865974 Plasmid-borne dna encoding peptide is expressed in bacterial host; transformation, genetic engineering |
09/12/1989 | US4865971 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils |
09/12/1989 | CA1259450A1 Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |